Document is current
Any future updates will be listed below
-
Authors
Uotani, Ryu
Miyazaki, Dai
Shimizu, Yumiko
Ohtani, Fumie
Haruki, Tomoko
Sasaki, Shin-ichi
Koyama, Ayumi
Inoue, Yoshitsugu
Suzutani, Tatsuo
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture (16K11322, 17K11481)
Alcon
Pfizer
- License Information
-
More Information
Article History
Received: 18 October 2021
Accepted: 28 February 2022
First Online: 30 March 2022
Competing interests
: Dai Miyazaki reports lecture fee from Santen Pharmaceutical, Senju Pharmaceutical, Alcon, outside the submitted work. Funding: Alcon, Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture, 16K11322. Yoshitsugu Inoue reports grants and lecture fee from Senju Pharmaceutical Co, Ltd., grants from Santen Pharmaceutical Co, Ltd., grants from Alcon Japan, Ltd., outside the submitted work. Funding: Pfizer, Alcon, Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture, 17K11481. Ryu Uotani, Yumiko Shimizu, Fumie Ohtani, Tomoko Haruki, Shin-ichi Sasaki, Ayumi Koyama, and Tatsuo Suzutani declare no competing interests.
